academic article

• Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker..  British journal of cancer.  101:1044-1050. 2009
• Phase 2 study of gemcitabine and irinotecan in metastatic breast cancer with correlatives to determine topoisomerase I localization as a predictor of response..  Cancer.  113:2646-2654. 2008
• Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study. 2007
• Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression..  Clinical cancer research : an official journal of the American Association for Cancer Research.  12:20-28. 2006
• Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells..  Clinical cancer research : an official journal of the American Association for Cancer Research.  12:11-19. 2006